mirtazapine has been researched along with Genetic Predisposition in 4 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maréchal, E | 1 |
| Beel, K | 1 |
| Crols, R | 1 |
| Hernalsteen, D | 1 |
| Willekens, B | 1 |
| Chang, HS | 3 |
| Won, ES | 1 |
| Lee, HY | 3 |
| Ham, BJ | 2 |
| Kim, YG | 1 |
| Lee, MS | 3 |
| Won, E | 1 |
| Kang, RH | 1 |
| Paik, JW | 1 |
| Jeong, YJ | 1 |
| Han, SW | 1 |
1 review available for mirtazapine and Genetic Predisposition
| Article | Year |
|---|---|
Long-Term Survival after Progressive Multifocal Leukoencephalopathy in a Patient with Primary Immune Deficiency and NFKB1 Mutation.
Topics: Disease Management; Disease Susceptibility; Genetic Predisposition to Disease; Humans; Leukoencephal | 2020 |
3 other studies available for mirtazapine and Genetic Predisposition
| Article | Year |
|---|---|
Association of ARRB1 polymorphisms with the risk of major depressive disorder and with treatment response to mirtazapine.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Arrestins; beta-Arrestin 1; beta-Arrestins; Depressiv | 2015 |
Association analysis for corticotropin releasing hormone polymorphisms with the risk of major depressive disorder and the response to antidepressants.
Topics: Adult; Antidepressive Agents; Biomarkers, Pharmacological; Case-Control Studies; Citalopram; Cortico | 2015 |
Association of the adrenergic alpha 2a receptor--1291C/G polymorphism with weight change and treatment response to mirtazapine in patients with major depressive disorder.
Topics: Adrenergic alpha-Antagonists; Adult; Depressive Disorder, Major; Female; Genetic Predisposition to D | 2009 |